Literature DB >> 2847750

Alteration of mast cell responsiveness to adenosine by pertussis toxin.

D L Marquardt1, L L Walker.   

Abstract

Adenosine potentiates mouse bone marrow-derived mast cell mediator release by a mechanism that appears to involve cell surface adenosine receptors. In an attempt to explore possible interactions between G proteins and adenosine receptors, mast cells were incubated with activated pertussis toxin, an agent that ADP-ribosylates and inactivates some G protein subtypes, prior to challenge with specific antigen or the calcium ionophore A23187. Mast cells preincubated with 10 ng/ml pertussis toxin for at least 2 hr exhibited an inhibition of antigen-induced beta-hexosaminidase and leukotriene C4 release. The ability of adenosine to potentiate beta-hexosaminidase release was attenuated to an even greater degree by pertussis toxin. A23187-stimulated mediator release was not altered by pertussis toxin, although a modest inhibition of the ability of adenosine to enhance A23187-induced beta-hexosaminidase release was observed in pertussis toxin-treated mast cells. Although up to 24-hr exposure to 100 ng/ml pertussis toxin did not alter resting mast cell cyclic AMP levels, the ability of adenosine to elevate cell cyclic AMP concentrations was diminished markedly by doses of the toxin higher than those required to affect mediator release. Neither antigen-stimulated intracellular free calcium level augmentation alone nor the additional potentiation of these levels by adenosine was changed by pertussis toxin treatment. Inositol trisphosphate was generated by mast cells stimulated by IgE-mediated mechanisms, but a preincubation with pertussis toxin did not influence its generation. In summary, adenosine appeared to produce some of its alterations in mast cell biochemical events by a mechanism that was partially inhibited by pertussis toxin. The nature of the G protein linked to the mast cell adenosine receptor is yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847750     DOI: 10.1016/0006-2952(88)90088-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Mast cell adenosine induced calcium mobilization via Gi3 and Gq proteins.

Authors:  H M Hoffman; L L Walker; D L Marquardt
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

3.  Distinct roles of Ca2+ mobilization and G protein usage on regulation of Toll-like receptor function in human and murine mast cells.

Authors:  Asifa K Zaidi; Elden Retna Raj B Thangam; Hydar Ali
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

4.  Adenosine stimulates Ca2+ fluxes and increases cytosolic free Ca2+ in cultured rat mesangial cells.

Authors:  A Olivera; A López-Rivas; J M López-Novoa
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

5.  Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells.

Authors:  S L Tilley; V A Wagoner; C A Salvatore; M A Jacobson; B H Koller
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Adenosine stimulates DNA fragmentation in human thymocytes by Ca(2+)-mediated mechanisms.

Authors:  Z Szondy
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

7.  Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.

Authors:  I Feoktistov; I Biaggioni
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

8.  Synergistic effects of calcium-mobilizing agents and adenosine on histamine release from rat peritoneal mast cells.

Authors:  M J Lohse; K Maurer; K N Klotz; U Schwabe
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.